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Abstract 
 
Psychostimulant drugs are widely used in children for the treatment of attention-
deficit/hyperactivity disorder (ADHD). Recent animal studies suggest that exposure to 
these agents in early life could be detrimental to brain development. Here for the first 
time, the effect of methylphenidate (MPH) and d-amphetamine (AMPH) on the 
expression of two key genes for neuronal development and plasticity, brain derived 
neurotrophic factor (bdnf) and the effector immediate early gene (IEG) activity-
regulated, cytoskeletal-associated protein (Arc), was examined in both juvenile and 
adult rats. Both MPH (2 mg/kg, i.p.) and AMPH (0.5mg/kg, i.p.) induced marked 
decreases of bdnf mRNA in hippocampal and cortical brain regions of juveniles, 
while effects in adults were significantly less (hippocampus) or opposite (frontal 
cortex). In comparison, Arc mRNA was decreased (hippocampus and parietal cortex), 
largely unaffected (frontal cortex) or increased (striatum) in juveniles, while in  adults 
Arc mRNA increased in most brain regions. MPH-induced locomotion was also 
measured and demonstrated a much smaller increase in juveniles compared to adults. 
In summary, our data show that the effects of MPH and AMPH on expression of the 
neurodevelopmentally important genes, bdnf and Arc differ markedly in juvenile and 
adult rats, with juveniles showing evidence of brain region-specific decreases in both 
genes. These age-dependent effects on gene expression may be linked with the 
reported long-term harmful effects of psychostimulants in animal models. 
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Introduction 
 
Reported prevalence rates of childhood attention-deficit/hyperactivity disorder 
(ADHD) vary from 2 % to as high as 18 %, depending on the diagnostic criteria used 
(Faraone et al., 2003). As a result, it has been suggested that not only ADHD sufferers 
but also large numbers of children who do not meet the full diagnostic criteria are 
subject to psychostimulant drug therapy for ADHD (Angold et al., 2000). Indeed, it is 
now established that the psychostimulants methylphenidate (MPH) and d-
amphetamine (AMPH) have a calming effect in children regardless of ADHD 
diagnosis (Rapoport & Inoff-Germain, 2002; Andersen, 2005).   
 
Given the widespread use of these drugs throughout one of the most plastic and 
sensitive phases of neurodevelopment, surprisingly little is known about the actions of 
these agents on the young brain. Indeed, there is increasing concern regarding the 
long-term effects of early life exposure to psychostimulants (Volkow & Insel, 2003; 
Robbins, 2002; Andersen et al., 2005; Grund et al., 2006).  
 
Previous studies, in adult animals and humans show that both MPH and AMPH target 
the brain monoamines, noradrenaline and dopamine, and it is assumed that similar 
effects occur in juveniles. Specifically these agents block monoamine re-uptake 
(MPH) and increase vesicular release (AMPH), and increase extracellular brain 
concentrations of both noradrenaline and dopamine (Kuczenski & Segal, 2001; 
Volkow et al, 2001). In adult and adolescent rats psychostimulants also evoke the 
expression of monoamine-regulated genes, including the immediate early gene (IEG) 
c-fos, in brain regions which receive major dopaminergic inputs such as striatum and 
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nucleus accumbens (Brandon & Steiner, 2003; Yano et al., 2006; Adriani et al., 2006; 
Cotterly et al., 2007). However, much less is known about psychostimulant action on 
gene expression in juveniles, particularly in regions with less dense monoaminergic 
inputs, such as hippocampus and cortex, which are important for key cognitive and 
emotional functions. 
 
Importantly, monoaminergic systems undergo pronounced neurodevelopmental 
changes during childhood and adolescence (Spear, 2000; Andersen, 2005). For 
example, the central dopamine system shows substantial re-organisation during 
development, including changes in dopamine fibre density, release, transporter levels 
and receptor numbers (Kalsbeek et al., 1988; Stamford et al., 1989; Teicher & 
Andersen, 1995; Tarazi et al., 1998; Moll et al., 2000).   
  
Previous experiments conducted in young rodents provide evidence that exposure to 
MPH in early life may disrupt brain maturation including developmental changes of 
D3 dopamine receptor expression in prefrontal cortex (Andersen, 2005; Andersen et 
al., 2008). Brain derived neurotrophic factor (BDNF) and the effector IEG, activity-
regulated, cytoskeletal-associated protein (Arc) are crucial for neural development 
and plasticity, as well as cognition and emotional behaviours (Altar et al., 1997; 
Schwartz et al., 1997; Guzowski et al., 2000; Lu et al., 2005; Tzingounis & Nicoll, 
2006). In the current study we assessed the effect of MPH and AMPH on mRNA 
expression of bdnf and Arc in both juvenile and adult rats, and found evidence for 
striking decreases in the expression of both genes in the juvenile but not adult brain. 
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Material and Methods 
 
Animals and drug treatment 
 
Juvenile (post natal day [PND] 20) and adult (PND>60) male Sprague-Dawley rats 
(Harlan Olac, Bicester, UK) were housed (6/group) in separate age-matched groups. 
at constant temperature and humidity under a 24 h light/dark cycle (lights on from 6 
am to 6 pm) with free access to food and water. All experiments were carried out in 
accordance with the UK Animals Scientific Procedures Act (1986) and Home Office 
guidelines. 
 
Following acclimatisation to the animal facilities (5 days), groups (6 rats/treatment 
group) of juvenile (PND 25, 80-95g) and adult (PND>60 days, 260-285g) rats were 
administered either 2 mg/kg MPH or 0.5 mg/kg AMPH. Similar doses of MPH 
administered chronically to young rats are reported to produce impairments of bdnf- 
and Arc-dependent processes in adulthood (Lagace et al, 2006; Gray et al, 2007). 
AMPH is normally used clinically at doses approximately 4 times lower than those of 
MPH (Kuczenski & Segal, 2001). Drugs (obtained from Sigma, U.K.) were dissolved 
in saline and corresponding age-matched control groups were injected with saline 
alone (1 ml/kg, i.p.). Rats were killed by rapid dislocation of the neck 2 h post-drug, 
and brains were removed, frozen in isopentane and stored in -80oC priot to sectioning 
using a cryostat. The rational behind the chosen time period of 2 h post-drug for 
killing the animals is based on previous studies by ourselves and others, 
measuring changes of bdnf and Arc mRNA expression after acute administration 
of various centrally acting drugs including MPH at this time point (Zetterström 
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et al, 1999; Pei et al, 2000: Chase et al, 2007). Separate groups of juvenile and adult 
rats were administered MPH (2mg/kg, i.p.) and tested for locomotor activity changes 
together with their age-matched controls given saline (for details see below). 
 
In situ hybridisation 
Brain sections (10 µm) were thaw-mounted on to pre-cleaned, ready to use super-frost 
glass slides (Menzel GmbH & Co KG, Germany) and pre-treated using a standard 
protocol as described previously (Pei et al., 1996).  Oligonucleotides complementary 
to mRNA were as follows: i) a 36 mer (5’ GGT CTC GTA GAA ATA TTG CTT 
CAG TTG GCC TTT TGA 3’) complementary to bases 878-913 of rat bdnf cDNA 
(Genbank accession number: BC087634.1) which encode all isoforms of the bdnf 
gene, ii) a 45 mer (5’ CTT GGT TGC CCA TCC TCA CCT GGC ACC CAA GAC 
TGG TAT TGC TGA 3’) complementary to bases 789-833 of rat Arc cDNA 
(Genbank accession number: NM019361.1). Oligonucleotides were 3’-tail labelled 
with 35S-dATP by terminal deoxynucleotide transferase and labelled probes (specific 
activity >109 cpm/µg) were added to each section (2 x 106 cpm/section) in 
hybridisation buffer as previously described (Pei et al., 1996). After incubation in 
humidity chambers (containing 50% formamide in 4 x Saline sodium citrate (SSC) at 
35oC (bdnf probe) or 36o C (Arc probe) for 14-16 h, slides were washed in 1 x SSC 
buffer at 55oC for 3 x 20 min followed by 2 x 60 min at room temperature, and then 
air-dried and exposed to autoradiography film (Biomax, Amersham, UK) for 5-7 days 
at room temperature. Controls included the use of oligonucleotides in the sense 
orientation and displacement with unlabelled probes. Searches with the Genbank 
database using the BLAST program revealed no significant homology of the 
nucleotide sequences with other previously characterised rodent genes. 
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Locomotor activity measurements 
Each animal was taken from the home cage, weighed, injected with MPH or saline 
and transferred with no prior habituation to a standard laboratory cage (43 x 43 x 35 
cm with saw dust bedding) placed between 15 horizontal infrared photocells (2.54 cm 
apart, Opto-Varimex-Mini, Columbus Instruments, Ohio). Spontaneous horizontal 
activity was registered as an locomotor count each time animal movement caused a 
beam break. Locomotor counts were recorded every 5th minute over 2 h after MPH or 
saline administration. All activity measurements were recorded between 10-12 am. 
 
Data analysis and Statistics  
 
The relative abundance of mRNA in areas of interest was determined by 
densitometric quantification of signals measured from autoradiograms using MCIDTM 
Core autoradiography software (InterFocus Imaging Ltd.). Optical density values 
were calibrated to 35S tissue equivalents using 14C microscales  (Amersham). After 
establishing standard curves, densitometric measurements were obtained from regions 
of interest in one of two ways. In the case of hippocampal areas (i.e. CA1, CA3 and 
DG), piriform cortex (at the level of medial prefrontal cortex) (see Fig 3b) and 
caudate nucleus (dorsal striatum - see Fig 6c), a series of non-overlapping point 
densitometric measurements were obtained bilaterally in 3 sections. Alternatively, in 
the case of parietal cortex (see Fig 3a), cingulate cortex, pre-limbic cortex (see Fig 
3b), orbital cortex (see Fig 6b) and caudate nucleus (see Fig 6c), densitometric 
measurements were made bilaterally in 3 sections using a fixed area quadrant. 
Bilateral densitometric values from 3 sections (ie. 6 measurements/region/rat) were 
averaged to provide 1 measurement/region/rat. Data are presented as group 
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mean+S.E.M. values (6 rats/group) and expressed as either nCi/g tissue or % changes 
of corresponding saline treated controls. For details of stereotaxic landmarks see 
legends for figures 3 and 6 (Paxinos & Watson, 2005).  
 
Raw data were analysed statistically (Graph-Pad Prism, version 4.00) prior to 
conversion to percentage values. Data from the in situ experiments were analysed 
statistically on a region-by-region basis, using Student’s unpaired two-tailed t-test. If 
data groups failed tests for normality or equal variance (conducted automatically 
by statistical software) the level of significance was tested with Mann-Whitney 
Rank Sum Test (this occurred in 4/76 comparisons). The multiple groups of 
locomotor data were analysed statistically by analysis of variance (two-way 
ANOVA, with age and MPH treatment as independent measures) followed by 
the Bonferroni post-hoc test. In all tests, P<0.05 was taken as the level of 
statistical significance. 
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Results 
 
Regional distribution of BDNF and Arc mRNA in juvenile and adult rat brain 
 
The regional distribution of the bdnf and Arc mRNA was determined by densitometric 
quantification of autoradiograms from saline-treated control groups, in juvenile and 
adult rats (Table 1). Bdnf mRNA abundance was unevenly distributed in the brain 
regions examined in both age groups, as previously described (Conner et al., 1997; 
Zetterström et al., 1999). Abundance of bdnf mRNA was however, significantly 
greater in CA3 and dentate gyrus (DG) in juvenile compared to adult rats, (t10=3.38, 
P<0.01, Student’s t-test and T=57, P=0.002, Mann-Whitney Sum Rank Test), 
respectively, (Table 1a).  
 
Arc mRNA abundance did not differ between juvenile and adult rats in areas of 
frontal cortex. However, there were noticeable differences between the two age 
groups in other regions. As with bdnf, Arc mRNA abundance was significantly higher 
in juveniles compared to adult rats in hippocampal regions: CA1 (t10=23.46, 
P<0.001), CA3 (t10=10.91, P<0.001) and DG (t10=17.37, P<0.001). In contrast, Arc 
mRNA abundance of dorsal striatum was significantly lower in juvenile compared to 
adult rats (t10=-5.97, P<0.001), (Table 1b).          
 
Age-dependent effect of MPH and AMPH on bdnf mRNA 
 
Effects of MPH and AMPH on bdnf mRNA abundance are illustrated in figures 1-3.  
Both drugs evoked striking age-dependent effects on bdnf mRNA throughout the 
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brain regions examined. Statistical analysis revealed significant differences in drug-
evoked changes in bdnf mRNA between juvenile and adult rats, in the following brain 
regions: CA1 (MPH, t10=-18.86, P<0.001 and AMPH, t10=-5.79, P<0.001), CA3 
(t10=-10.69, P<0.001 and t10=-18.95, P<0.001), DG (t10=-14.34, P<0.001 and t10=-
22.23, P<0.001), parietal cortex (t10=-9.91, P<0.001 and t10=-2.43, P<0.05) (figs 1a 
and 2a). Bdnf mRNA in regions of the frontal cortex of juvenile and adult rats was 
similarly different: cingulate cortex (MPH, t10=-12.63, P<0.001 and AMPH, t10=-
4.79, P<0.001), prelimbic cortex (t10=-8.94, P<0.001 and t10=-14.59, P<0.001), 
piriform cortex (t10=-13.85, P<0.001 and t10=-13.86, P<0.001), respectively (figs 1b 
and 2b).  
 
In juvenile rats, compared to saline controls, MPH induced marked reductions in bdnf 
mRNA in hippocampal sub-regions (CA1, t10=6.24 P<0.001; CA3, t10=8.61 P<0.001; 
DG, t10=18.62 P<0.001) and parietal cortex (t10=7.79, P<0.001) (fig 1a). Similar 
reductions in bdnf mRNA were detected in hippocampal sub-regions of juvenile rats 
after AMPH (Fig 2a). In comparison, in adult rats MPH and AMPH either evoked 
small reductions or did not affect bdnf mRNA in hippocampus and parietal cortex 
(figs 1a, 2a and 3a).  
 
This age-dependent effect of MPH and AMPH on bdnf mRNA was even more 
pronounced in regions of the frontal cortex, Thus, in these regions MPH and AMPH 
reduced bdnf mRNA in juvenile rats, but increased bdnf mRNA in adult rats (figs 1b, 
2b and 3b). Statistically significant differences for the action of MPH in juvenile 
versus adult rats were detected in cingulate cortex (t10= -12.62, P<0.001), prelimbic 
cortex (t10= -8.94, P<0.001), piriform cortex (t10= -13.85, P<0.001) (fig 1b). 
Page 10 of 50
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901 1(434)817-2040 ext. 167
European Journal of Neuroscience
F
o
r P
eer R
eview
 11 
Corresponding results for AMPH were: cingulate cortex (t10= -4.80, P<0.001), 
prelimbic cortex (t10= -14.60, P<0.001) and piriform cortex (t10= -13.87, P<0.001) 
(fig 2b).  
 
Age-dependent effects of MPH and AMPH on Arc mRNA 
 
The effect of MPH and AMPH on Arc mRNA abundance was also measured in 
juvenile and adult rats. As with bdnf mRNA, Arc mRNA showed clear evidence of 
age-dependent differences in sensitivity to MPH and AMPH. In DG of juvenile rats, 
both drugs significantly reduced Arc mRNA (MPH, t10=17.56 P<0.001; AMPH, 
t10=17.00 P<0.001) (figs 4a and 5a), and this reduction was greater in juveniles 
compared to adults for both MPH (t10=-7.03, P<0.001) and AMPH (t10=-7.79, 
P<0.001) (figs 4a and 5a). Moreover, in CA1 whereas MPH and AMPH decreased 
Arc mRNA in juveniles, both drugs increased Arc mRNA in this region of adults 
(MPH, t10=-25.98 P<0.001; AMPH, T=21 P=0.002).  
 
As with hippocampus, Arc mRNA in other cortical regions responded differently 
between juvenile and adult rats. In the case of parietal cortex, Arc mRNA showed no 
change after MPH and a small but significant decrease (-25%) after AMPH (T=56, 
P=0.004) in juvenile rats, whereas in adult rats both drugs evoked striking increases 
(+60 %) in Arc mRNA (MPH, t10=-6.62 P<0.001; AMPH, t10=-10.54 P<0.001) (figs 
4a, 5a and 6a). Similarly, in both cingulate and orbital cortices Arc mRNA showed a 
striking increase (+95-115 %) in response to MPH (T=21, P=0.002) and AMPH (t10=-
9.98, P<0.001) in adult rats, but much smaller changes were observed in juveniles 
(figs 4b, 5b). Finally, in caudate nucleus both drugs increased Arc mRNA expression 
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more in the juvenile rats compared to the adult rats, and this difference was 
particularly pronounced for MPH (+80 % and +30 % for juvenile and adults,  
respectively (t10=10.16, P<0.001) (figs. 4b, 5b). 
 
Age-dependent effects of MPH on locomotor activity 
The effect of MPH on locomotor activity in juvenile and adult rats is shown in fig 7. 
This effect was different in juvenile and adult rats and there was a highly significant 
interaction of age and MPH treatment on locomotor activity over the total 2 h post 
injection period (F1,20=34.23, P<0.0001, two-way ANOVA). While MPH treated 
juvenile rats showed a trend to increase in locomotor activity compared to saline 
controls, statistical analysis with Bonferroni post-hoc test revealed that MPH did not 
significantly increase locomotor activity in the juvenile rats, neither over the total 2 h 
time period or at any 15 min period illustrated in fig 7, (saline versus MPH, P>0.05). 
In comparison, adult rats treated with MPH showed significantly more locomotor 
counts over the total 2 h time period compared to their corresponding saline treated 
control group (saline versus MPH, P<0.001, Bonferroni post-hoc test) and this 
difference was apparent at each 15 min period of the 2 h time course, with the greatest 
difference occurring 30-75 min post-drug (fig. 7).  
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Discussion 
The psychostimulant drugs MPH and AMPH are widely used in children for the 
treatment of attention-deficit/hyperactivity disorder (ADHD), but recent data suggest 
that exposure to these agents in early life could be detrimental to brain development. 
The present study sought for the first time to compare the effect of MPH and AMPH 
on adult and juvenile rats in terms of changes in expression of two key genes for brain 
development and plasticity, bdnf and Arc. The data show striking age-dependent 
effects of MPH and AMPH on bdnf and Arc mRNA expression in brain regions 
implicated in the mechanisms of action of psychostimulants in the treatment of 
ADHD (Solanto, 1998; Volkow et al, 2001; Andersen, 2005). 
  
Both MPH and AMPH induced marked reductions in bdnf mRNA abundance 
throughout hippocampus and parietal cortex of juvenile rats, while in the adult rats 
decreases in these regions were minor in comparison. In areas of the frontal cortex the 
age-dependent effects were even more dramatic, with the drugs having opposite 
effects in adult and juveniles. Specifically, the data show that in these regions both 
MPH and AMPH evoked significant reductions of bdnf mRNA in juvenile rats, 
whereas in adult rats the drugs increased bdnf gene expression (see figs 1-3). 
 
In common with their effects on bdnf gene expression, MPH and AMPH also showed 
marked age-dependent effects on Arc gene expression. For example, in the adult rats, 
both psychostimulants significantly increased Arc mRNA in the CA1 region of the 
hippocampus and cortical areas, while in juvenile rats the drugs had little (frontal 
cortex) or the opposite effect (hippocampus and parietal cortex). The finding of a lack 
of effect of MPH and AMPH on Arc gene expression in specific regions of the frontal 
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cortex in juvenile rats agrees with a recent study demonstrating that MPH did not 
change Arc mRNA levels in the whole frontal cortex of juvenile rats (Chase et al., 
2007).  
 
In addition to the above, our data showing that MPH induced much less locomotion in 
juvenile compared to adult rats is consistent with previous studies investigating the 
age-dependent behavioural action of psychomotor stimulants in rodents (Bolaños et 
al., 1998; Spear, 2000; Andersen, 2005). Behavioural activation (including increased 
locomotion) is known to enhance hippocampal and cortical bdnf and Arc gene 
expression (Russo-Neustadt et al., 2000; Vazdarjanova et al., 2006). Therefore, it is 
possible that the greater locomotor effect of MPH seen in adults compared to 
juveniles is related to the findings that MPH generally induced larger increases 
(frontal cortex) or smaller decreases (hippocampus) in bdnf and Arc expression in the 
adults compared to the juveniles.  
 
The age-dependent effects observed in the present study are unlikely due to 
differences in the pharmacokinetic profile of MPH and AMPH in juvenile and adult 
rats because psychostimulant-evoked gene responses did not follow a consistent 
pattern. For example, the psychostimulant-induced reduction in hippocampal bdnf  
was greater in juvenile versus adult rats whereas the psychostimulant-induced 
increase in cortical Arc expression was smaller in juvenile versus adult rats. Therefore 
it seems more likely that the age-related effects reflect developmental differences in 
brain responsiveness to the psychostimulants. Indeed, marked maturation continues 
between adolescence and adulthood (Spear, 2000) specifically in regions such as the 
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pre-frontal cortex and hippocampus which showed clear-cut age-dependent to the 
psychostimulants.  
 
Importantly, both the dopamine and noradrenaline systems, which are main targets for 
MPH and AMPH, undergo pronounced neurodevelopmental changes throughout 
juvenile and adolescent life. For example, previous studies indicate that compared to 
adults, juvenile rats have a higher dopamine ‘tone’ including, lower density of  
dopamine transporters and increased depolarization-induced dopamine release in vitro 
(Stachowiak et al., 1987; Stamford et al., 1989; Coulter et al., 1996; Moll et al., 
2000). Age-dependent shifts in dopamine D1:D2 receptor density, and re-distribution 
of the vesicular-mediated transporter 2, have also been reported (Andersen, 2002; 
Hanson et al., 2004). In the case of the noradrenaline system, juvenile are different 
from adult rats in terms of shifts in noradrenaline turnover, increased in vitro release 
response to blockade of the noradrenaline transporter and reduced 2 autoreceptor 
function (Choi et al., 1997; Sanders et al., 2005). 
 
It is possible that the age-dependent effects on gene expression observed here are due 
to adult versus juvenile differences in psychostimulant-induced increases in 
extracellular monoamines. In vivo microdialysis studies show that MPH and AMPH 
increase extracellular monoamine levels in the brain of both juvenile and adult rats 
(Zetterström et al., 1983; Hurd & Ungerstedt, 1989; Kuczenski & Segal, 2001; 
Berridge et al., 2006). However, experiments directly comparing the effects of MPH 
and/or AMPH in adult and juvenile rats have to our knowledge, not been conducted.  
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In the present study, measurements of bdnf and Arc expression were done at 2 h 
after injections of MPH or AMPH. Previous studies in adult rats have shown 
that psychostimulants induce a short-lasting (0.5-3 h) increase followed by a 
delayed (6-24 h) fall in expression of some but not all IEG mRNAs (Yano & 
Steiner, 2005). The dynamics of psychostimulant-induced IEG mRNA changes in 
juvenile rats are currently unknown and it cannot be fully excluded that these 
are different in the two age groups i.e., a faster onset in fall of gene expression in 
juveniles compared to adults. If this is the case, it could explain the differences 
between the two age groups on Arc gene expression in hippocampus and cortex 
(more psychostimulant induced inhibition of mRNA expression in juveniles 
compared to adults) but not in striatum where the juvenile rats showed larger 
increases compared to the adults at 2 h after MPH or AMPH administration.  
 
It is conceivable that the age-dependent changes in bdnf and Arc mRNA in response 
to psychostimulant administration reflect a difference in the amino acid 
neurotransmitters, GABA and glutamate between juvenile and adult rats. Thus, the 
psychostimulants may evoke monoamine receptor-mediated changes in GABA and 
glutamate transmission and this may have down stream effects on bdnf and Arc 
expression. In support of this hypothesis, GABA reduces bdnf mRNA and glutamate 
stimulates Arc mRNA expression (Zafra et al., 1991; Heese et al., 2000; Khundakar 
& Zetterström, 2002), Moreover, age-related differences in these brain amino acid 
systems in cortical and hippocampal regions of the brain are reported (Swann et al., 
1993; Waters et al., 1997; Sabau et al., 1999; Potier et al., 2006; Liao & Malinow, 
1996). 
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Numerous studies show that psychostimulant treatment evokes pronounced changes 
in expression of a variety of genes in the caudate nucleus (striatum) (Yano & Steiner, 
2007). In the present study basal levels of striatal bdnf mRNA were undetectable. This 
finding is consistent with previous studies demonstrating that BDNF protein in 
striatum originates from pre-frontal cortex projection neurons (Altar et al., 1997; 
Conner et al., 1997). In contrast, striatal neurons express readily detectable levels of 
Arc mRNA and the corresponding protein, and our finding of increased striatal Arc 
gene expression in both juvenile and adult rats following MPH and AMP is consistent 
with previous studies of IEG expression in rats of different ages (Brandon & Steiner, 
2003; Adriani et al., 2006). Of particular relevance to the present study, it has recently 
been reported that both systemic and oral dosing of MPH increases striatal Arc 
mRNA and protein in juvenile rats (Chase et al., 2007). The present study found that 
both MPH and AMPH increased Arc mRNA in striatum and that this effect was more 
pronounced in the juveniles compared to the adults. Interestingly, striatal Arc gene 
expression is triggered by a dopamine D1 receptor-induced increase in cAMP levels, 
and previous studies report enhanced D1 receptor expression and function in the 
juvenile striatum compared to the adult (Gelbard et al., 1989; Andersen, 2002; Moro 
et al., 2007).   
 
The current finding of psychostimulant-induced decreases in bdnf expression in 
juvenile hippocampus and cerebral cortex, combined with the recognised importance 
of BDNF for normal neuronal development, survival and synaptic plasticity, 
highlights the possibility for harmful effects of psychostimulants on the developing 
brain. The potential seriousness of the reduced bdnf gene expression in young animals 
is underlined by our recent findings that the effect is dose-dependent, detected at half 
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of the dose used in the present study, and sustained following chronic treatment 
(Banerjee & Zetterström, 2007; 2008). Monoamine systems rely on BDNF for normal 
development (Akbarian et al., 2002; Dluzen et al., 2002; Sokoloff et al., 2002) and 
the present findings may therefore be linked to recent studies demonstrating that adult 
rats treated with MPH during early life (PND 20-35) show electrophysiological and 
behavioural evidence of decreased monoamine function in adulthood (Andersen et al., 
2002; Bolaños et al., 2003; Brandon et al., 2003; Carlezon et al., 2003). Recent 
studies demonstrating impairments of BDNF- and Arc-dependent processes such as 
hippocampal neurogenesis and memory in adult rats treated with MPH during 
development may also be related to the findings of the present study (Lagace et al., 
2006; LeBlanc-Duchin & Taukulis, 2007).   
 
Conclusion 
The present study demonstrates evidence of clear-cut differences in the responses of 
the juvenile and adult brain to administration of the psychostimulants MPH and 
AMPH. In the majority of brain areas examined these drugs induced a reduction in 
bdnf and Arc gene expression in the juveniles, while in adults the expression of these 
genes was generally increased. These results are highly relevant to recent studies in 
juvenile animals, using similar dosing regimes of MPH to the present study, 
demonstrating alteration in behavioural models of depression, anxiety and cognition 
later in life. How the present study and the majority of similar previous animal studies 
translate into the clinical situation will require further experiments including those 
using oral doses of MPH which produce plasma levels comparable with those seen in 
young children. 
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Table and figure legends 
 
Table 1: Table illustrating regional brain distribution of the bdnf mRNA (a) and Arc 
mRNA (b) in areas of interest from saline treated juvenile and adult control rats. 
Values (nCi/g tissue weight, mean+S.E.M., n=6 rats/group) were determined by 
densitometric quantification of autoradiograms. *P<0.01 and **P<0.001 (juvenile 
versus adult group). Abbreviations: DG, dentate gyrus; Par Cx, parietal cortex; Cing 
Cx, cingulate cortex; Pre Limb Cx, pre limbic cortex; Pir Cx, Piriform cortex.  
 
Fig 1: Age-dependent effects of MPH (2 mg/kg, i.p.) on bdnf mRNA in hippocampal 
sub-regions and parietal cortex (a), and regions of the frontal cortex (b). 
Measurements were taken 2 h post-drug. Data are expressed as % of saline-treated 
controls (1 ml/kg, i.p.) each column represents mean ± S.E.M. value from 5-6 rats. 
*P<0.05 and **P<0.001 compared to corresponding age matched saline injected 
controls; +P<0.001 compared to adult MPH group. Abbreviations: DG, dentate gyrus; 
Par Cx, parietal cortex; Cing Cx, cingulate cortex; Pre Limb Cx, pre limbic cortex; Pir 
Cx, Piriform cortex. 
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Fig 2: Age-dependent effects of AMPH (0.5 mg/kg, i.p.) on bdnf mRNA in 
hippocampal sub-regions and parietal cortex (a), and in regions of the frontal cortex 
(b). Measurements were taken 2 h post-drug. Data are expressed as % of saline-
treated controls (1 ml/kg, i.p.) each column represents mean ± S.E.M. value from 5-6 
rats.  *P<0.05 and **P<0.001 compared to corresponding age matched saline injected 
controls; +P<0.001 compared to adult AMPH group. Abbreviations as in legend to 
figure 1.  
 
 Figure 3: Representative autoradiograms showing the age-dependent effect of MPH 
(2 mg/kg, i.p.) on bdnf mRNA expression in hippocampal sub-regions and parietal 
cortex (a), and in regions of the frontal cortex (b). Abbreviations as in legend to figure 
1. Stereotaxic landmarks from Bregma (Paxinos & Watson, 2005) were: -3.48 to -3.60 
mm (figure a) and +3.24 to +3.72 mm (figure b). 
  
Figure 4: Age-dependent effects of MPH (2 mg/kg, i.p.) on Arc mRNA in 
hippocampal sub-regions and parietal cortex (a), and in regions of the frontal cortex 
and caudate putamen (b). Measurements were taken 2 h post-drug. Data are expressed 
as % of saline treated controls (1 ml/kg, i.p.) each column represents mean ± S.E.M. 
value from 5-6 rats.  *P<0.05 and **P<0.001 compared to corresponding age 
matched saline injected controls; +P<0.001 compared to adult MPH group. 
Abbreviations: DG, dentate gyrus; Par Cx, parietal cortex; Cing Cx, cingulate cortex; 
CPu, caudate putamen (dorso medial striatum). 
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Figure 5: Age-dependent effects of AMPH (0.5 mg/kg, i.p.) on Arc mRNA in 
hippocampal sub-regions and parietal cortex (a), and in regions of the frontal cortex 
and caudate putamen (b). Measurements were taken 2 h post-drug. Data are expressed 
as % of saline treated controls. Each column represents mean ± S.E.M. value from 5-6 
rats.  *P<0.05 and **P<0.001 compared to corresponding age matched saline injected 
controls; +P<0.001 compared to adult AMPH group. Abbreviations as in legend to 
figure 4. 
 
Figure 6: Representative autoradiograms showing the age dependent effect of MPH 
(2 mg/kg, i.p.) on Arc mRNA expression in hippocampal sub-regions, parietal cortex 
(a), regions of the frontal cortex (b) and the caudate putamen (c). Abbreviations as in 
legend to figure 4. Stereotaxic landmarks from Bregma (Paxinos & Watson, 2005) 
were: -3.48 to -3.60 mm (a), +3.24 to +3.72 mm (b) and +0.36 to +0.48 mm (c).  
 
Fig 7: Effects of MPH (2 mg/kg, i.p.) on locomotion in juvenile and adult rats. Each 
bar shows cummulated counts/15 min. Rats were administered saline or MPH and 
placed without prior habituation in cages equipped with infrared photocells. Each 
point is mean+S.E.M. value (6 rats/treatment group). *P<0.05, **P<0.01, 
***P<0.001, compared to the corresponding age matched saline treated control group 
(ANOVA  followed by the Bonferroni post-hoc test).  
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